Home Cart 0 Sign in  

[ CAS No. 105812-81-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 105812-81-5
Chemical Structure| 105812-81-5
Structure of 105812-81-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 105812-81-5 ]

Related Doc. of [ 105812-81-5 ]

Alternatived Products of [ 105812-81-5 ]

Product Details of [ 105812-81-5 ]

CAS No. :105812-81-5 MDL No. :MFCD06658161
Formula : C13H18FNO Boiling Point : -
Linear Structure Formula :- InChI Key :CXRHUYYZISIIMT-AAEUAGOBSA-N
M.W : 223.29 Pubchem ID :2734218
Synonyms :
Chemical Name :(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine

Calculated chemistry of [ 105812-81-5 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.54
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 66.07
TPSA : 23.47 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.42
Log Po/w (XLOGP3) : 1.82
Log Po/w (WLOGP) : 1.89
Log Po/w (MLOGP) : 2.42
Log Po/w (SILICOS-IT) : 2.45
Consensus Log Po/w : 2.2

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.52
Solubility : 0.68 mg/ml ; 0.00304 mol/l
Class : Soluble
Log S (Ali) : -1.93
Solubility : 2.61 mg/ml ; 0.0117 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.16
Solubility : 0.153 mg/ml ; 0.000685 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.35

Safety of [ 105812-81-5 ]

Signal Word:Danger Class:9
Precautionary Statements:P501-P273-P270-P264-P280-P391-P301+P312+P330-P305+P351+P338+P310 UN#:3077
Hazard Statements:H302-H318-H411 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 105812-81-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 105812-81-5 ]
  • Downstream synthetic route of [ 105812-81-5 ]

[ 105812-81-5 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 335158-58-2 ]
  • [ 105812-81-5 ]
YieldReaction ConditionsOperation in experiment
78.4%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 10℃;
Stage #2: for 0.5 h;
31.4g of trans-N-methyl-4'-fluorophenyl-3-carbomethoxypiperidine and 100mL of tetrahydrofuran were added into a 500mL round bottom flask with an agitator, a condenser and a thermometer, followed by an addition of 3. 31g of lithium aluminium hydride while maintaining the temperature at 10C and the mixture was agitated. After the reaction was completed, 50mL of distilled water and 30 mL of 10percent sodium hydroxide aqueous solution were slowly added, followed by agitation for 30 minutes. Then, 200mL of ethyl acetate was further added and then the mixture was agitated for another 30 minutes. The organic phase was separated from the aqueous phase and distilled off the solvent and low boiling organic materials. The remainder was recrystallized using a mixed solution of toluene and n-heptane to obtain trans-N-methyl-4'-fluorophenyl-3-hydroxymethylpiperidine (yield: 78.4percent, purity: 99.3percent). Rf= 0.3 (dichloromethane/methanol, 4/1) 'H NMR (CDCl3, (200MHz): 7.18 (t, 2H, J=8.7 Hz); 6.98 (t, 2H, J=8.7 Hz); 3.39 (dd, [1H,] J=10. 6 Hz, J=2.8 Hz); 3.25~3.14 (m, 2H); 2.93 (d, 1H, J=10.8 Hz); 2.70 (s, 1H) ; 2.31 (s, 3H); 2. 27~2. 21 (m, [1H)] ; 2.09~1.75 (m, 5H)
Reference: [1] Patent: WO2004/5254, 2004, A1, . Location in patent: Page 9
[2] Patent: WO2005/63707, 2005, A1, . Location in patent: Page 26
[3] Patent: WO2005/63707, 2005, A1, . Location in patent: Page 27
  • 2
  • [ 188302-25-2 ]
  • [ 105812-81-5 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran; toluene at 15 - 65℃;
Stage #2: With water; sodium hydroxide In tetrahydrofuran; toluene at 0 - 5℃; for 0.333333 h;
Lithium aluminum hydride (1.8 g, 47.49 mmol) was added to a mixture of tetrahydrofuron (15.0 mL) and toluene (5.0 mL) at 0-5 °C and stirred for 15 min at the same temperature. A solution of (3S,4R)-3-ethoxycarbonyl-4-(4'-fluorophenyl)-N-methyl piperidine-2,6-dione 6 (5.0 g, 17.05 mmol) in toluene (15.0 mL) was added slowly for 45-60 min at below 15 °C and the mixture was heated to 60-65 °C for 2 h. The mixture was cooled to 0-5 °C and basified with 10percent sodium hydroxide solution. Water (10.0 mL) was charged to the reaction mixture and then stirred for 20 min. The separated solid was filtered and washed with toluene (2 .x. 15 mL). The solvent was removed under reduced pressure and the crude compound was recrystalized from n-heptane to afford 7 (3.0 g, 80percent) as an white solid. inlMMLBox (c 1, ethanol); IR (cm-1): 3153, 2943, 1602, 1509, 1222, 1379, 1069; 1H NMR: (400 MHz, CDCl3) δ, ppm: 7.14-7.17 (m, 2H), 6.96-7.0 (m, 2H), 3.38-3.42 (m, 1H), 3.13-3.25 (m, 2H), 2.92-2.95 (m, 1H), 2.29-2.34 (m, 4H), 1.97-2.03 (m, 5H); MS: m/z: 224.2 [M+H+].
Reference: [1] Tetrahedron Asymmetry, 2011, vol. 22, # 1, p. 1 - 3
  • 3
  • [ 858938-15-5 ]
  • [ 105812-81-5 ]
Reference: [1] Patent: WO2005/63707, 2005, A1, . Location in patent: Page 30
[2] Patent: US2007/112031, 2007, A1, . Location in patent: Page/Page column 35
[3] Patent: US2007/112031, 2007, A1, . Location in patent: Page/Page column 35
  • 4
  • [ 459-32-5 ]
  • [ 105812-81-5 ]
Reference: [1] Tetrahedron Asymmetry, 2011, vol. 22, # 1, p. 1 - 3
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 105812-81-5 ]

Fluorinated Building Blocks

Chemical Structure| 125224-43-3

[ 125224-43-3 ]

((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol

Similarity: 0.96

Chemical Structure| 37656-48-7

[ 37656-48-7 ]

4-(4-Fluorophenyl)piperidine

Similarity: 0.83

Chemical Structure| 6716-98-9

[ 6716-98-9 ]

4-(4-Fluorophenyl)piperidine hydrochloride

Similarity: 0.82

Chemical Structure| 676495-94-6

[ 676495-94-6 ]

3-(4-Fluorophenyl)piperidine

Similarity: 0.82

Chemical Structure| 3929-30-4

[ 3929-30-4 ]

4-(4-Fluorophenyl)piperidin-4-ol hydrochloride

Similarity: 0.80

Aryls

Chemical Structure| 125224-43-3

[ 125224-43-3 ]

((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol

Similarity: 0.96

Chemical Structure| 37656-48-7

[ 37656-48-7 ]

4-(4-Fluorophenyl)piperidine

Similarity: 0.83

Chemical Structure| 6716-98-9

[ 6716-98-9 ]

4-(4-Fluorophenyl)piperidine hydrochloride

Similarity: 0.82

Chemical Structure| 676495-94-6

[ 676495-94-6 ]

3-(4-Fluorophenyl)piperidine

Similarity: 0.82

Chemical Structure| 3929-30-4

[ 3929-30-4 ]

4-(4-Fluorophenyl)piperidin-4-ol hydrochloride

Similarity: 0.80

Alcohols

Chemical Structure| 125224-43-3

[ 125224-43-3 ]

((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol

Similarity: 0.96

Chemical Structure| 3929-30-4

[ 3929-30-4 ]

4-(4-Fluorophenyl)piperidin-4-ol hydrochloride

Similarity: 0.80

Chemical Structure| 488787-59-3

[ 488787-59-3 ]

(S)-4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile

Similarity: 0.71

Chemical Structure| 103146-26-5

[ 103146-26-5 ]

4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hydrobromide

Similarity: 0.70

Chemical Structure| 612532-52-2

[ 612532-52-2 ]

3-Amino-3-(4-fluorophenyl)propan-1-ol

Similarity: 0.67

Related Parent Nucleus of
[ 105812-81-5 ]

Piperidines

Chemical Structure| 125224-43-3

[ 125224-43-3 ]

((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol

Similarity: 0.96

Chemical Structure| 37656-48-7

[ 37656-48-7 ]

4-(4-Fluorophenyl)piperidine

Similarity: 0.83

Chemical Structure| 6716-98-9

[ 6716-98-9 ]

4-(4-Fluorophenyl)piperidine hydrochloride

Similarity: 0.82

Chemical Structure| 676495-94-6

[ 676495-94-6 ]

3-(4-Fluorophenyl)piperidine

Similarity: 0.82

Chemical Structure| 3929-30-4

[ 3929-30-4 ]

4-(4-Fluorophenyl)piperidin-4-ol hydrochloride

Similarity: 0.80